K Number
K992762
Device Name
BRACHYVISION 6.0
Date Cleared
2000-03-09

(205 days)

Product Code
Regulation Number
892.5050
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Brachyvision 6.0 is designed to allow the dose distribution of an implant or applicator to be individually shaped for each patient. Brachy Vision is a general purpose brachytherapy planning system used for prospective and confirmation dose calculations for patients undergoing a course of brachytherapy, using either temporary or permanent implants of various radioisotopes. Brachy Vison 6.0 may be used for any brachytherapy planning activity, but has been specifically optimized for use with remote afterloaders (especially the VariSource unit from Varian), and for use with 3D images such as may be obtained from CT or MRI, or Ultrasound images.
Device Description
Brachy Vision is a computer based product used for calculating and displaying prospective or verification treatment plans for particular patients undergoing a course of Brachytherapy. The system consists of a computer with graphics display, film scanner input, and plotter output. Patient data may be entered from network connection, via the film scanner, via the optional back lit digitizer, or via the keyboard. Source placement information may be added to the patient data and isodose distributions, which would result from those source placements, may be displayed, analyzed and plotted. For use with remote afterloader devices, source dwell times may be optimized to user selected criteria.
More Information

Not Found

Not Found

No
The summary describes a traditional brachytherapy planning system focused on dose calculation and display, with no mention of AI or ML terms or functionalities.

No
This device is a brachytherapy planning system, which calculates and displays dose distributions for treatment plans. It does not directly provide therapy.

No

The device is a treatment planning system for brachytherapy, used for dose calculations and optimization, not for diagnosing a medical condition.

No

The device description explicitly states the system consists of a computer with graphics display, film scanner input, and plotter output, indicating it includes hardware components beyond just software.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used to provide information for diagnosis, monitoring, or screening.
  • Brachyvision's Function: Brachyvision 6.0 is a treatment planning system for brachytherapy. It uses patient imaging data (CT, MRI, Ultrasound, film) to calculate and display dose distributions for radiation sources placed within or near a patient's body. This is a process related to treatment delivery, not diagnostic testing of biological samples.

The description clearly states its purpose is for "prospective and confirmation dose calculations for patients undergoing a course of brachytherapy" and "planning activity." This falls under the category of medical device software used for treatment planning and delivery, not in vitro diagnostic testing.

N/A

Intended Use / Indications for Use

Brachy Vision is a general purpose brachytherapy planning system used for prospective and confirmation dose calculations for patients undergoing a course of brachytherapy, using either temporary or permanent implants of various radioisotopes.

Brachy Vison 6.0 may be used for any brachytherapy planning activity, but has been specifically optimized for use with remote afterloaders (especially the VariSource unit from Varian), and for use with 3D images such as may be obtained from CT or MRI, or Ultrasound images.

Product codes (comma separated list FDA assigned to the subject device)

90 MUJ

Device Description

Brachy Vision is a computer based product used for calculating and displaying prospective or verification treatment plans for particular patients undergoing a course of Brachytherapy. The system consists of a computer with graphics display, film scanner input, and plotter output. Patient data may be entered from network connection, via the film scanner, via the optional back lit digitizer, or via the keyboard. Source placement information may be added to the patient data and isodose distributions, which would result from those source placements, may be displayed, analyzed and plotted. For use with remote afterloader devices, source dwell times may be optimized to user selected criteria.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

CT or MRI, or Ultrasound images

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

Nucletron Plato Brachytherapy

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 892.5050 Medical charged-particle radiation therapy system.

(a)
Identification. A medical charged-particle radiation therapy system is a device that produces by acceleration high energy charged particles (e.g., electrons and protons) intended for use in radiation therapy. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, component parts, and accessories.(b)
Classification. Class II. When intended for use as a quality control system, the film dosimetry system (film scanning system) included as an accessory to the device described in paragraph (a) of this section, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

0

Image /page/0/Picture/1 description: The image shows the logo for Varian Oncology Systems. The word "varian" is in bold, followed by a circled symbol. Below that, the words "oncology systems" are written in a smaller, non-bold font. The logo is simple and professional.

Image /page/0/Picture/2 description: The image shows a series of handwritten numbers and letters. The characters appear to be 'Ka92762'. The handwriting is somewhat messy and the characters are not perfectly formed, but they are still legible. The image is in black and white.

Premarket Notification [510K] Summary as required by 21 CFR 807.92

Page 1 of 2

Date Summary was prepared:

August 12, 1999

Submitter's Name:

Varian Medical Systems 3100 Hansen Way Palo Alto, CA 94304

Contact Person:

Linda S. Nash Regulatory Affairs and Quality Assurance Manager Phone (650) 424-6990 (650) 855-7364 FAX E-Mail linda.nash@os.varian.com

Device Name: Brachyvision 6.0

Classification Name: Source, Brachytherapy, Radionuclide

Predicate Device: Nucletron Plato Brachytherapy

Image /page/0/Picture/13 description: The image shows the logo for "Partners for Life". The word "Partners" is stacked on top of the word "For", and the word "Life" is written in a cursive font to the right of the other two words. The logo is in black and white.

Varian Associates, Inc. 3045 Hanover Street Palo Alto, California 94304-1129 U.S.A. 650.493.4000 FAX: 650.424.4830

{ } printed on recycled paper

1

Product Description:

Brachy Vision is a computer based product used for calculating and displaying prospective or verification treatment plans for particular patients undergoing a course of Brachytherapy. The system consists of a computer with graphics display, film scanner input, and plotter output. Patient data may be entered from network connection, via the film scanner, via the optional back lit digitizer, or via the keyboard. Source placement information may be added to the patient data and isodose distributions, which would result from those source placements, may be displayed, analyzed and plotted. For use with remote afterloader devices, source dwell times may be optimized to user selected criteria.

Intended Use:

Brachyvision 6.0 is designed to allow the dose distribution of an implant or applicator to be individually shaped for each patient. Brachy Vision is a general purpose brachytherapy planning system used for prospective and confirmation dose calculations for patients undergoing a course of brachytherapy, using either temporary or permanent implants of various radioisotopes.

Technological Characteristics:

See Specifications/Features Comparison Chart

2

Food and Drug Administration

9200 Corporate Boulevard Rockville MD 20850

Image /page/2/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three heads facing to the right. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle.

MAR 9 2000

Linda Nash Regulatory Affairs & Quality Assurance Manager Varian Associates, Inc. 3045 Hanover Street Palo Alto. California 94304-1129

Re:

K992762 BrachyVision 6.0 Dated: December 13, 1999 Received: December 14, 1999 Regulatory Class: II 21 CFR 892.5730/Procode: 90 MUJ

Dear Ms. Nash:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce pror to May 26, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalion assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4591. Additionally, for question and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Daniel G. Schultz, M.D.

Captain, USPHS Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure(s)

3

varian@ oncology systems

Indications For Use

510(k) Number (if known): _ 192762

Device Name: Brachyvision 6.0

Indications for Use:

Brachy Vison 6.0 may be used for any brachytherapy planning activity, but has been specifically optimized for use with remote afterloaders (especially the VariSource unit from Varian), and for use with 3D images such as may be obtained from CT or MRI, or Ultrasound images.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use _ OR (per 21 CFR 801.109)

Over-The-Counter Use___

David A. Simpson
(Division Sign-Off)

(Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological D 510(k) Number

Image /page/3/Picture/12 description: The image shows a logo for "Partners for Life". The words "Partners For" are stacked on top of each other in a bold, sans-serif font. The word "Life" is written in a cursive font and is placed below the words "Partners For". The logo is black and white.

Varian Associates, Inc. 3045 Hanover Street Palo Alto, California 94304-1129 U.S.A. 650.493.4000 FAX: 650.424.4830

€ > printed on recycled papes